FDA approves leukaemia drug Marqibo
06:25 EDT 10 Aug 2012 | InPharm
The Food and Drug Administration has given the green light for Talon Therapeutics’ Marqibo to combat a rare form of leukaemia. The US regulator has approved Marqibo (vincristine sulfate liposome injection) to treat adults with Philadelphia chromoso..
Original Article: FDA approves leukaemia drug Marqibo
More From BioPortfolio on "FDA approves leukaemia drug Marqibo"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
